TSC2 directly interacts with PC-1 to inhibit mTOR signaling, and the loss of PC-1 in ADPKD is thought to be attributed to inappropriate mTOR activity (Brook-Carter et al., 1994; Shillingford et al., 2006). Here, TSC2 is linked to autosomal dominant polycystic kidney disease.